vimarsana.com

Page 7 - Harvard Wyss Institute For Biologically Inspired Engineering News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Tender Food Raises $12M in Seed Funding

Sherlock Biosciences secures $80M to bring molecular diagnostics to the home

Diagnostics developer Sherlock Biosciences has advanced its molecular diagnostic capabilities, which can now produce faster results on low-cost devices. The startup will use its Series B round of funding to expand the reach of its technology, potentially placing it directly in the hands of consumers around the world.

Alkem Licenses Technology from Harvard University, Aiming to Treat Ischemic Injury and Vascular Diseases

Alkem signs license agreement with Harvard to develop, commercialize new technology for treating ischemic conditions

Alkem Laboratories Limited, an Indian multinational pharmaceutical company, has signed a license agreement with Harvard University's Office of Technology Development enabling Alkem to develop and commercialize a novel technology that may help meet the dire need for effective treatment of diabetic neuropathy, foot ulcers, peripheral arterial disease (PAD), and other injuries caused by vascular disease.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.